Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Blood Sugar Control in Type 2 Diabetes
NCT02691897Phase 1Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Melatonin with Placebo (2 arms). Primary endpoints: Fasting Blood Sugar at 3 months and Glycated Hemoglobin at 3 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02691897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02691897.